Floatz logo

ISOFLURANE

Breast Neoplasms

Nanjing Medical UniversitySmall moleculePhase 4 / ApprovedDormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
51/ 100
Competitive Position
65/ 100

Competitive context

177 Active assets in the Breast Neoplasms cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
Merck Sharp & Dohme LLC
Phase 4BB
Letrozole
Fujian Cancer Hospital
Phase 4BB
EXEMESTANE
Fujian Cancer Hospital
Phase 4BB
Docetaxel
Universitas Airlangga
Phase 4BB
Inno-206
Merck Sharp & Dohme LLC
Phase 4BB

View all 50 →

Same molecule, other indications

ISOFLURANE is also rated in:

subarachnoid hemorrhageDormant
BB
Indicative ·
66 / 100
View asset →
deliriumDormant
BB
Indicative ·
66 / 100
View asset →
Post Operative Cognitive DysfunctionDormant
BB
Indicative ·
66 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →